Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Molecular Cancer Therapeutics
|
April 16, 2015
The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression
Manali S Phadke, Patrizia Sini, Keiran S M Smalley
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines
Manali S Phadke, Natalia F Krynetskaia, Anurag K Mishra, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Natalia F Krynetskaia, Manali S Phadke, Sachin H Jadhav, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models
Manali S Phadke, Jiannong Li, Zhihua Chen, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models
Manali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Neuro-Oncology
|
September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular Analyses
Yolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Cancer Immunology Research
|
November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma
Larissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Jiannong Li, Inna Smalley, Zhihua Chen, et al.
Cancer Immunology Research
|
March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Manali S Phadke, Zhihua Chen, Jiannong Li, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Molecular Cancer Therapeutics
|
April 16, 2015
The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression
Manali S Phadke, Patrizia Sini, Keiran S M Smalley
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines
Manali S Phadke, Natalia F Krynetskaia, Anurag K Mishra, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Natalia F Krynetskaia, Manali S Phadke, Sachin H Jadhav, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models
Manali S Phadke, Jiannong Li, Zhihua Chen, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models
Manali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Neuro-Oncology
|
September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular Analyses
Yolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Cancer Immunology Research
|
November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant Melanoma
Larissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy
Jiannong Li, Inna Smalley, Zhihua Chen, et al.
Cancer Immunology Research
|
March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Manali S Phadke, Zhihua Chen, Jiannong Li, et al.
Page
of 1